Levodopa-carbidopa intestinal gel therapy in Parkinson’s disease: Procedure complications

Popa, Luminita Celia; Leucuţa, Daniel-Corneliu; Tohănean, Nicoleta; Popa, Stefan-Lucian; Perju‐Dumbravă, Lăcrămioara

doi:10.37897/rjn.2020.2.5

Cited by 1 publication

(1 citation statement)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Among the therapeutic options for advanced PD, only Levodopa-carbidopa intestinal gel (LCIG) and deep brain stimulation (DBS) are currently available in Romania. The LCIG has gained increased attention from the Romanian researchers, with the publication of 11 studies [114,118,120,125,126,132,[138][139][140]142,143]. However, no studies on DBS were published in Romania, possibly due to the limited availability of the procedure.…”

Section: Discussionmentioning

confidence: 99%

Parkinson’s Disease in Romania: A Scoping Review

et al. 2021

View full text Add to dashboard Cite

Parkinson’s disease (PD) is a significant cause of disability, with a fast-growing prevalence. This review summarizes the epidemiological and clinical data, research on the diagnostic approaches and the interventions available in the Eastern European country of Romania. This scoping review follows the recommendations on the scoping review methodology by Joanna Briggs Institute. We searched four databases (up to 27 January 2021). The data of eligible studies were extracted in standardized forms. We identified 149 unique studies from 1133 records, with 11 epidemiological studies, 52 studies investigating clinical aspects of PD, 35 studies on diagnostic tools, and 51 intervention studies. A narrative synthesis is provided and placed in a historical context. Our review revealed a considerable increase in the Romanian research on PD in the latest 15 years, which largely follows international trends. However, we also identified several research gaps that provide useful information for policymakers, public health specialists, and clinicians.

show abstract